Bionano Genomics, Inc. (BNGO) has an estimated market capitalization of 445.39 mln USD as of today. According to the latest financial report, its revenue at the end of fiscal year 2021-12-31 was 6.30 mln USD and net earnings were -0.08 USD per share.
A closer look at BNGO’s revenue history reveals that it has been decreasing steadily since 2022-03-01 when it was 6.30 mln USD, dropping to 5.70 mln USD on 2022-05-05 and further down to 667,000 USD by 2022-08-04. As of 2023-03-07, the expected revenue was estimated at 6790000 USD with no reported earnings per share (EPS).
To sum up, Bionano Genomics’ financial situation is not very good due to its low and decreasing revenue over the past years. However, the company may be able to turn things around if they are able to increase their revenue in the upcoming quarters and make more profit from their operations.